Literature DB >> 19526250

Glucokinase regulatory protein gene polymorphism affects postprandial lipemic response in a dietary intervention study.

Haiqing Shen1, Toni I Pollin, Coleen M Damcott, John C McLenithan, Braxton D Mitchell, Alan R Shuldiner.   

Abstract

Postprandial triglyceridemia is an emerging risk factor for cardiovascular disease. However, most of the genes that influence postprandial triglyceridemia are not known. We evaluated whether a common nonsynonymous SNP rs1260326/P446L in the glucokinase regulatory protein (GCKR) gene influenced variation in the postprandial lipid response after a high-fat challenge in seven hundred and seventy participants in the Amish HAPI Heart Study who underwent an oral high-fat challenge and had blood samples taken in the fasting state and during the postprandial phase at 1, 2, 3, 4, and 6 h. We found that the minor T allele at rs1260326 was associated with significantly higher fasting TG levels after adjusting for age, sex, and family structure (P (a) = 0.06 for additive model, and P (r) = 0.0003 for recessive model). During the fat challenge, the T allele was associated with significantly higher maximum TG level (P (a) = 0.006), incremental maximum TG level (P (a) = 0.006), TG area under the curve (P (a) = 0.02) and incremental TG area under the curve (P (a) = 0.03). Our data indicate that the rs1260326 T allele of GCKR is associated with both higher fasting levels of TG as well as the postprandial TG response, which may result in higher atherogenic risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526250      PMCID: PMC2918876          DOI: 10.1007/s00439-009-0700-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.

Authors:  E D Slosberg; U J Desai; B Fanelli; I St Denny; S Connelly; M Kaleko; B R Boettcher; S L Caplan
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus.

Authors:  Kitt F Petersen; Gerald I Shulman
Journal:  Am J Cardiol       Date:  2002-09-05       Impact factor: 2.778

Review 4.  Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes.

Authors:  André C Carpentier
Journal:  Diabetes Metab       Date:  2008-03-18       Impact factor: 6.041

Review 5.  Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity.

Authors:  Neil B Ruderman; Asish K Saha; Edward W Kraegen
Journal:  Endocrinology       Date:  2003-09-18       Impact factor: 4.736

6.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

7.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Authors:  Sekar Kathiresan; Olle Melander; Candace Guiducci; Aarti Surti; Noël P Burtt; Mark J Rieder; Gregory M Cooper; Charlotta Roos; Benjamin F Voight; Aki S Havulinna; Björn Wahlstrand; Thomas Hedner; Dolores Corella; E Shyong Tai; Jose M Ordovas; Göran Berglund; Erkki Vartiainen; Pekka Jousilahti; Bo Hedblad; Marja-Riitta Taskinen; Christopher Newton-Cheh; Veikko Salomaa; Leena Peltonen; Leif Groop; David M Altshuler; Marju Orho-Melander
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

8.  Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media.

Authors:  B G Nordestgaard; R Wootton; B Lewis
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-04       Impact factor: 8.311

9.  Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans.

Authors:  Y P Zhou; V Grill
Journal:  J Clin Endocrinol Metab       Date:  1995-05       Impact factor: 5.958

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  10 in total

1.  A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort.

Authors:  Danielle M Greenawalt; Radu Dobrin; Eugene Chudin; Ida J Hatoum; Christine Suver; John Beaulaurier; Bin Zhang; Victor Castro; Jun Zhu; Solveig K Sieberts; Susanna Wang; Cliona Molony; Steven B Heymsfield; Daniel M Kemp; Marc L Reitman; Pek Yee Lum; Eric E Schadt; Lee M Kaplan
Journal:  Genome Res       Date:  2011-05-20       Impact factor: 9.043

2.  Polymorphisms in the GCKR are associated with serum lipid traits, the risk of coronary artery disease and ischemic stroke.

Authors:  Yi-Jiang Zhou; Shao-Cai Hong; Rui-Xing Yin; Qian Yang; Xiao-Li Cao; Wu-Xian Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.

Authors:  Toni I Pollin; Kathleen A Jablonski; Jarred B McAteer; Richa Saxena; Sekar Kathiresan; Steven E Kahn; Ronald B Goldberg; David Altshuler; Jose C Florez
Journal:  J Clin Endocrinol Metab       Date:  2011-04-27       Impact factor: 5.958

4.  GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?

Authors:  Márton Mohás; Péter Kisfali; Luca Járomi; Anita Maász; Eszter Fehér; Veronika Csöngei; Noémi Polgár; Eniko Sáfrány; Judit Cseh; Katalin Sümegi; Katalin Hetyésy; István Wittmann; Béla Melegh
Journal:  Cardiovasc Diabetol       Date:  2010-11-29       Impact factor: 9.951

5.  Genomics of post-prandial lipidomic phenotypes in the Genetics of Lipid lowering Drugs and Diet Network (GOLDN) study.

Authors:  Marguerite R Irvin; Degui Zhi; Stella Aslibekyan; Steven A Claas; Devin M Absher; Jose M Ordovas; Hemant K Tiwari; Steve Watkins; Donna K Arnett
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

6.  Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes.

Authors:  Hirotaka Matsuo; Ken Yamamoto; Hirofumi Nakaoka; Akiyoshi Nakayama; Masayuki Sakiyama; Toshinori Chiba; Atsushi Takahashi; Takahiro Nakamura; Hiroshi Nakashima; Yuzo Takada; Inaho Danjoh; Seiko Shimizu; Junko Abe; Yusuke Kawamura; Sho Terashige; Hiraku Ogata; Seishiro Tatsukawa; Guang Yin; Rieko Okada; Emi Morita; Mariko Naito; Atsumi Tokumasu; Hiroyuki Onoue; Keiichi Iwaya; Toshimitsu Ito; Tappei Takada; Katsuhisa Inoue; Yukio Kato; Yukio Nakamura; Yutaka Sakurai; Hiroshi Suzuki; Yoshikatsu Kanai; Tatsuo Hosoya; Nobuyuki Hamajima; Ituro Inoue; Michiaki Kubo; Kimiyoshi Ichida; Hiroshi Ooyama; Toru Shimizu; Nariyoshi Shinomiya
Journal:  Ann Rheum Dis       Date:  2015-02-02       Impact factor: 19.103

Review 7.  A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.

Authors:  Paola Dongiovanni; Luca Valenti
Journal:  Int J Mol Sci       Date:  2017-07-16       Impact factor: 5.923

8.  Quantile-dependent expressivity of postprandial lipemia.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2020-02-26       Impact factor: 3.240

9.  Evaluating machine learning-powered classification algorithms which utilize variants in the GCKR gene to predict metabolic syndrome: Tehran Cardio-metabolic Genetics Study.

Authors:  Mahdi Akbarzadeh; Nadia Alipour; Hamed Moheimani; Asieh Sadat Zahedi; Firoozeh Hosseini-Esfahani; Hossein Lanjanian; Fereidoun Azizi; Maryam S Daneshpour
Journal:  J Transl Med       Date:  2022-04-09       Impact factor: 5.531

Review 10.  Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies.

Authors:  Tingyu Fang; Hua Wang; Xiaoyue Pan; Peter J Little; Suowen Xu; Jianping Weng
Journal:  Int J Biol Sci       Date:  2022-09-06       Impact factor: 10.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.